Company: BIAF
Filing Date: 2025-06-02
Form Type: DEF 14A
Source: 0001641172-25-013280
Chunk: 32

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-02
Form: DEF 14A
Chunk 32
---
 |
| ● | based                                                                                                                                                                                                                                                  
 on the final Reverse Stock Split Ratio, the per share exercise price of all outstanding warrants will be increased proportionately,                                                                                                                    
 and the number of shares of Common Stock issuable upon the exercise of all outstanding warrants will be reduced proportionately;                                                                                                                       
 and                                                                                                                                                                                                                                                    |
| ● | the number of shares reserved for issuance pursuant to any outstanding equity awards and any maximum number of shares with respect to which equity awards may be granted will be reduced proportionately based on the final Reverse Stock Split Ratio. |

The following table sets forth the approximate
number of shares of the Common Stock that would be outstanding immediately after the Reverse Stock Split based on the current authorized
number of shares of Common Stock at various exchange ratios, based on 28,459,541 shares of Common Stock actually issued and outstanding
as of May 29, 2025. The table does not account for fractional shares that will be paid in cash.

|                                                                                                                                                                                                                                  |     | Estimated      
 Number of      
 Shares of      
 Common Stock   
 Before Reverse 
 Stock Split    |             |     | Estimated        
 Number of        
 Shares of        
 Common Stock     
 After Reverse    
 Stock Split on a 
 1-for-10 basis   |             |     | Estimated        
 Number of        
 Shares of        
 Common Stock     
 After Reverse    
 Stock Split on a 
 1-for-25 basis   |             |
| Authorized Common Stock as of the Record Date                                                                                                                                                                                    |     |                | 100,000,000 |     |                  | 100,000,000 |     |                  | 100,000,000 |
| Shares of Common Stock issued and outstanding                                                                                                                                                                                    |     |                |  28,459,541 |     |                  |   2,845,954 |     |                  |   1,138,381 |
| Shares of Common Stock issuable under outstanding options, warrants or reserved for issuance under existing plans                                                                                                                |     |                |  29,903,730 |     |                  |   2,990,373 |     |                  |   1,196,149 |
| Shares of Common Stock authorized but unissued (Authorized Common Stock minus issued and outstanding shares, shares issuable upon outstanding options, warrants and shares reserved for issuance under existing incentive plans) |     |                |  41,636,729 |     |                  |  94,163,673 |     |                  |  97,665,470 |
| Shares of